Global Follicle Stimulating Hormone Market Growth 2025-2031

March 2025 | 97 pages | ID: G693AC7B24BEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global Follicle Stimulating Hormone market size is predicted to grow from US$ 1351 million in 2025 to US$ 1604 million in 2031; it is expected to grow at a CAGR of 2.9% from 2025 to 2031.

Follicle stimulating hormone (FSH) is a hormone made by the pituitary gland that affects the gonads (female ovaries and males testes). In females, it stimulates growth of the ovarian follicles.

Due to less pollution, recombinant FSH takes large proportion in market. In 2019, recombinant FSH takes about 82% of Poland follicle stimulating hormone consumption market share.

There are only several companies producing this product, such as Merck Serono, MSD, IBSA, Ferring, Livzon and Techwell etc. Merck Serono and MSD are Top 2 companies in the world. In 2019, Merck Serono takes about 55% of Poland follicle stimulating hormone revenue. MSD takes about 18% of Poland follicle stimulating hormone revenue.

LP Information, Inc. (LPI) ' newest research report, the “Follicle Stimulating Hormone Industry Forecast” looks at past sales and reviews total world Follicle Stimulating Hormone sales in 2024, providing a comprehensive analysis by region and market sector of projected Follicle Stimulating Hormone sales for 2025 through 2031. With Follicle Stimulating Hormone sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Follicle Stimulating Hormone industry.

This Insight Report provides a comprehensive analysis of the global Follicle Stimulating Hormone landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Follicle Stimulating Hormone portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Follicle Stimulating Hormone market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Follicle Stimulating Hormone and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Follicle Stimulating Hormone.

This report presents a comprehensive overview, market shares, and growth opportunities of Follicle Stimulating Hormone market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Recombinant FSH
• Urinary FSH

Segmentation by Application:

• Infertility Treatment
• Assisted Reproductive Technology

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Merck Serono
• MSD
• IBSA
• Ferring
• Livzon
• Techwell
• GenSci
• Gedeon Richter
• Teva

Key Questions Addressed in this Report

What is the 10-year outlook for the global Follicle Stimulating Hormone market?

What factors are driving Follicle Stimulating Hormone market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Follicle Stimulating Hormone market opportunities vary by end market size?

How does Follicle Stimulating Hormone break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Follicle Stimulating Hormone Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Follicle Stimulating Hormone by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Follicle Stimulating Hormone by Country/Region, 2020, 2024 & 2031
2.2 Follicle Stimulating Hormone Segment by Type
  2.2.1 Recombinant FSH
  2.2.2 Urinary FSH
2.3 Follicle Stimulating Hormone Sales by Type
  2.3.1 Global Follicle Stimulating Hormone Sales Market Share by Type (2020-2025)
  2.3.2 Global Follicle Stimulating Hormone Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Follicle Stimulating Hormone Sale Price by Type (2020-2025)
2.4 Follicle Stimulating Hormone Segment by Application
  2.4.1 Infertility Treatment
  2.4.2 Assisted Reproductive Technology
2.5 Follicle Stimulating Hormone Sales by Application
  2.5.1 Global Follicle Stimulating Hormone Sale Market Share by Application (2020-2025)
  2.5.2 Global Follicle Stimulating Hormone Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Follicle Stimulating Hormone Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Follicle Stimulating Hormone Breakdown Data by Company
  3.1.1 Global Follicle Stimulating Hormone Annual Sales by Company (2020-2025)
  3.1.2 Global Follicle Stimulating Hormone Sales Market Share by Company (2020-2025)
3.2 Global Follicle Stimulating Hormone Annual Revenue by Company (2020-2025)
  3.2.1 Global Follicle Stimulating Hormone Revenue by Company (2020-2025)
  3.2.2 Global Follicle Stimulating Hormone Revenue Market Share by Company (2020-2025)
3.3 Global Follicle Stimulating Hormone Sale Price by Company
3.4 Key Manufacturers Follicle Stimulating Hormone Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Follicle Stimulating Hormone Product Location Distribution
  3.4.2 Players Follicle Stimulating Hormone Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR FOLLICLE STIMULATING HORMONE BY GEOGRAPHIC REGION

4.1 World Historic Follicle Stimulating Hormone Market Size by Geographic Region (2020-2025)
  4.1.1 Global Follicle Stimulating Hormone Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Follicle Stimulating Hormone Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Follicle Stimulating Hormone Market Size by Country/Region (2020-2025)
  4.2.1 Global Follicle Stimulating Hormone Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Follicle Stimulating Hormone Annual Revenue by Country/Region (2020-2025)
4.3 Americas Follicle Stimulating Hormone Sales Growth
4.4 APAC Follicle Stimulating Hormone Sales Growth
4.5 Europe Follicle Stimulating Hormone Sales Growth
4.6 Middle East & Africa Follicle Stimulating Hormone Sales Growth

5 AMERICAS

5.1 Americas Follicle Stimulating Hormone Sales by Country
  5.1.1 Americas Follicle Stimulating Hormone Sales by Country (2020-2025)
  5.1.2 Americas Follicle Stimulating Hormone Revenue by Country (2020-2025)
5.2 Americas Follicle Stimulating Hormone Sales by Type (2020-2025)
5.3 Americas Follicle Stimulating Hormone Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Follicle Stimulating Hormone Sales by Region
  6.1.1 APAC Follicle Stimulating Hormone Sales by Region (2020-2025)
  6.1.2 APAC Follicle Stimulating Hormone Revenue by Region (2020-2025)
6.2 APAC Follicle Stimulating Hormone Sales by Type (2020-2025)
6.3 APAC Follicle Stimulating Hormone Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Follicle Stimulating Hormone by Country
  7.1.1 Europe Follicle Stimulating Hormone Sales by Country (2020-2025)
  7.1.2 Europe Follicle Stimulating Hormone Revenue by Country (2020-2025)
7.2 Europe Follicle Stimulating Hormone Sales by Type (2020-2025)
7.3 Europe Follicle Stimulating Hormone Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Follicle Stimulating Hormone by Country
  8.1.1 Middle East & Africa Follicle Stimulating Hormone Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Follicle Stimulating Hormone Revenue by Country (2020-2025)
8.2 Middle East & Africa Follicle Stimulating Hormone Sales by Type (2020-2025)
8.3 Middle East & Africa Follicle Stimulating Hormone Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Follicle Stimulating Hormone
10.3 Manufacturing Process Analysis of Follicle Stimulating Hormone
10.4 Industry Chain Structure of Follicle Stimulating Hormone

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Follicle Stimulating Hormone Distributors
11.3 Follicle Stimulating Hormone Customer

12 WORLD FORECAST REVIEW FOR FOLLICLE STIMULATING HORMONE BY GEOGRAPHIC REGION

12.1 Global Follicle Stimulating Hormone Market Size Forecast by Region
  12.1.1 Global Follicle Stimulating Hormone Forecast by Region (2026-2031)
  12.1.2 Global Follicle Stimulating Hormone Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Follicle Stimulating Hormone Forecast by Type (2026-2031)
12.7 Global Follicle Stimulating Hormone Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Merck Serono
  13.1.1 Merck Serono Company Information
  13.1.2 Merck Serono Follicle Stimulating Hormone Product Portfolios and Specifications
  13.1.3 Merck Serono Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Merck Serono Main Business Overview
  13.1.5 Merck Serono Latest Developments
13.2 MSD
  13.2.1 MSD Company Information
  13.2.2 MSD Follicle Stimulating Hormone Product Portfolios and Specifications
  13.2.3 MSD Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 MSD Main Business Overview
  13.2.5 MSD Latest Developments
13.3 IBSA
  13.3.1 IBSA Company Information
  13.3.2 IBSA Follicle Stimulating Hormone Product Portfolios and Specifications
  13.3.3 IBSA Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 IBSA Main Business Overview
  13.3.5 IBSA Latest Developments
13.4 Ferring
  13.4.1 Ferring Company Information
  13.4.2 Ferring Follicle Stimulating Hormone Product Portfolios and Specifications
  13.4.3 Ferring Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Ferring Main Business Overview
  13.4.5 Ferring Latest Developments
13.5 Livzon
  13.5.1 Livzon Company Information
  13.5.2 Livzon Follicle Stimulating Hormone Product Portfolios and Specifications
  13.5.3 Livzon Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Livzon Main Business Overview
  13.5.5 Livzon Latest Developments
13.6 Techwell
  13.6.1 Techwell Company Information
  13.6.2 Techwell Follicle Stimulating Hormone Product Portfolios and Specifications
  13.6.3 Techwell Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Techwell Main Business Overview
  13.6.5 Techwell Latest Developments
13.7 GenSci
  13.7.1 GenSci Company Information
  13.7.2 GenSci Follicle Stimulating Hormone Product Portfolios and Specifications
  13.7.3 GenSci Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 GenSci Main Business Overview
  13.7.5 GenSci Latest Developments
13.8 Gedeon Richter
  13.8.1 Gedeon Richter Company Information
  13.8.2 Gedeon Richter Follicle Stimulating Hormone Product Portfolios and Specifications
  13.8.3 Gedeon Richter Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 Gedeon Richter Main Business Overview
  13.8.5 Gedeon Richter Latest Developments
13.9 Teva
  13.9.1 Teva Company Information
  13.9.2 Teva Follicle Stimulating Hormone Product Portfolios and Specifications
  13.9.3 Teva Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2020-2025)
  13.9.4 Teva Main Business Overview
  13.9.5 Teva Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Follicle Stimulating Hormone Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Follicle Stimulating Hormone Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Recombinant FSH
Table 4. Major Players of Urinary FSH
Table 5. Global Follicle Stimulating Hormone Sales by Type (2020-2025) & (K Doses)
Table 6. Global Follicle Stimulating Hormone Sales Market Share by Type (2020-2025)
Table 7. Global Follicle Stimulating Hormone Revenue by Type (2020-2025) & ($ million)
Table 8. Global Follicle Stimulating Hormone Revenue Market Share by Type (2020-2025)
Table 9. Global Follicle Stimulating Hormone Sale Price by Type (2020-2025) & (USD/Dose)
Table 10. Global Follicle Stimulating Hormone Sale by Application (2020-2025) & (K Doses)
Table 11. Global Follicle Stimulating Hormone Sale Market Share by Application (2020-2025)
Table 12. Global Follicle Stimulating Hormone Revenue by Application (2020-2025) & ($ million)
Table 13. Global Follicle Stimulating Hormone Revenue Market Share by Application (2020-2025)
Table 14. Global Follicle Stimulating Hormone Sale Price by Application (2020-2025) & (USD/Dose)
Table 15. Global Follicle Stimulating Hormone Sales by Company (2020-2025) & (K Doses)
Table 16. Global Follicle Stimulating Hormone Sales Market Share by Company (2020-2025)
Table 17. Global Follicle Stimulating Hormone Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Follicle Stimulating Hormone Revenue Market Share by Company (2020-2025)
Table 19. Global Follicle Stimulating Hormone Sale Price by Company (2020-2025) & (USD/Dose)
Table 20. Key Manufacturers Follicle Stimulating Hormone Producing Area Distribution and Sales Area
Table 21. Players Follicle Stimulating Hormone Products Offered
Table 22. Follicle Stimulating Hormone Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Follicle Stimulating Hormone Sales by Geographic Region (2020-2025) & (K Doses)
Table 26. Global Follicle Stimulating Hormone Sales Market Share Geographic Region (2020-2025)
Table 27. Global Follicle Stimulating Hormone Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Follicle Stimulating Hormone Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Follicle Stimulating Hormone Sales by Country/Region (2020-2025) & (K Doses)
Table 30. Global Follicle Stimulating Hormone Sales Market Share by Country/Region (2020-2025)
Table 31. Global Follicle Stimulating Hormone Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Follicle Stimulating Hormone Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Follicle Stimulating Hormone Sales by Country (2020-2025) & (K Doses)
Table 34. Americas Follicle Stimulating Hormone Sales Market Share by Country (2020-2025)
Table 35. Americas Follicle Stimulating Hormone Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Follicle Stimulating Hormone Sales by Type (2020-2025) & (K Doses)
Table 37. Americas Follicle Stimulating Hormone Sales by Application (2020-2025) & (K Doses)
Table 38. APAC Follicle Stimulating Hormone Sales by Region (2020-2025) & (K Doses)
Table 39. APAC Follicle Stimulating Hormone Sales Market Share by Region (2020-2025)
Table 40. APAC Follicle Stimulating Hormone Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Follicle Stimulating Hormone Sales by Type (2020-2025) & (K Doses)
Table 42. APAC Follicle Stimulating Hormone Sales by Application (2020-2025) & (K Doses)
Table 43. Europe Follicle Stimulating Hormone Sales by Country (2020-2025) & (K Doses)
Table 44. Europe Follicle Stimulating Hormone Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Follicle Stimulating Hormone Sales by Type (2020-2025) & (K Doses)
Table 46. Europe Follicle Stimulating Hormone Sales by Application (2020-2025) & (K Doses)
Table 47. Middle East & Africa Follicle Stimulating Hormone Sales by Country (2020-2025) & (K Doses)
Table 48. Middle East & Africa Follicle Stimulating Hormone Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Follicle Stimulating Hormone Sales by Type (2020-2025) & (K Doses)
Table 50. Middle East & Africa Follicle Stimulating Hormone Sales by Application (2020-2025) & (K Doses)
Table 51. Key Market Drivers & Growth Opportunities of Follicle Stimulating Hormone
Table 52. Key Market Challenges & Risks of Follicle Stimulating Hormone
Table 53. Key Industry Trends of Follicle Stimulating Hormone
Table 54. Follicle Stimulating Hormone Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Follicle Stimulating Hormone Distributors List
Table 57. Follicle Stimulating Hormone Customer List
Table 58. Global Follicle Stimulating Hormone Sales Forecast by Region (2026-2031) & (K Doses)
Table 59. Global Follicle Stimulating Hormone Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Follicle Stimulating Hormone Sales Forecast by Country (2026-2031) & (K Doses)
Table 61. Americas Follicle Stimulating Hormone Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Follicle Stimulating Hormone Sales Forecast by Region (2026-2031) & (K Doses)
Table 63. APAC Follicle Stimulating Hormone Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Follicle Stimulating Hormone Sales Forecast by Country (2026-2031) & (K Doses)
Table 65. Europe Follicle Stimulating Hormone Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Follicle Stimulating Hormone Sales Forecast by Country (2026-2031) & (K Doses)
Table 67. Middle East & Africa Follicle Stimulating Hormone Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Follicle Stimulating Hormone Sales Forecast by Type (2026-2031) & (K Doses)
Table 69. Global Follicle Stimulating Hormone Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Follicle Stimulating Hormone Sales Forecast by Application (2026-2031) & (K Doses)
Table 71. Global Follicle Stimulating Hormone Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Merck Serono Basic Information, Follicle Stimulating Hormone Manufacturing Base, Sales Area and Its Competitors
Table 73. Merck Serono Follicle Stimulating Hormone Product Portfolios and Specifications
Table 74. Merck Serono Follicle Stimulating Hormone Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 75. Merck Serono Main Business
Table 76. Merck Serono Latest Developments
Table 77. MSD Basic Information, Follicle Stimulating Hormone Manufacturing Base, Sales Area and Its Competitors
Table 78. MSD Follicle Stimulating Hormone Product Portfolios and Specifications
Table 79. MSD Follicle Stimulating Hormone Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 80. MSD Main Business
Table 81. MSD Latest Developments
Table 82. IBSA Basic Information, Follicle Stimulating Hormone Manufacturing Base, Sales Area and Its Competitors
Table 83. IBSA Follicle Stimulating Hormone Product Portfolios and Specifications
Table 84. IBSA Follicle Stimulating Hormone Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 85. IBSA Main Business
Table 86. IBSA Latest Developments
Table 87. Ferring Basic Information, Follicle Stimulating Hormone Manufacturing Base, Sales Area and Its Competitors
Table 88. Ferring Follicle Stimulating Hormone Product Portfolios and Specifications
Table 89. Ferring Follicle Stimulating Hormone Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 90. Ferring Main Business
Table 91. Ferring Latest Developments
Table 92. Livzon Basic Information, Follicle Stimulating Hormone Manufacturing Base, Sales Area and Its Competitors
Table 93. Livzon Follicle Stimulating Hormone Product Portfolios and Specifications
Table 94. Livzon Follicle Stimulating Hormone Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 95. Livzon Main Business
Table 96. Livzon Latest Developments
Table 97. Techwell Basic Information, Follicle Stimulating Hormone Manufacturing Base, Sales Area and Its Competitors
Table 98. Techwell Follicle Stimulating Hormone Product Portfolios and Specifications
Table 99. Techwell Follicle Stimulating Hormone Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 100. Techwell Main Business
Table 101. Techwell Latest Developments
Table 102. GenSci Basic Information, Follicle Stimulating Hormone Manufacturing Base, Sales Area and Its Competitors
Table 103. GenSci Follicle Stimulating Hormone Product Portfolios and Specifications
Table 104. GenSci Follicle Stimulating Hormone Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 105. GenSci Main Business
Table 106. GenSci Latest Developments
Table 107. Gedeon Richter Basic Information, Follicle Stimulating Hormone Manufacturing Base, Sales Area and Its Competitors
Table 108. Gedeon Richter Follicle Stimulating Hormone Product Portfolios and Specifications
Table 109. Gedeon Richter Follicle Stimulating Hormone Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 110. Gedeon Richter Main Business
Table 111. Gedeon Richter Latest Developments
Table 112. Teva Basic Information, Follicle Stimulating Hormone Manufacturing Base, Sales Area and Its Competitors
Table 113. Teva Follicle Stimulating Hormone Product Portfolios and Specifications
Table 114. Teva Follicle Stimulating Hormone Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 115. Teva Main Business
Table 116. Teva Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Follicle Stimulating Hormone
Figure 2. Follicle Stimulating Hormone Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Follicle Stimulating Hormone Sales Growth Rate 2020-2031 (K Doses)
Figure 7. Global Follicle Stimulating Hormone Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Follicle Stimulating Hormone Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Follicle Stimulating Hormone Sales Market Share by Country/Region (2024)
Figure 10. Follicle Stimulating Hormone Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Recombinant FSH
Figure 12. Product Picture of Urinary FSH
Figure 13. Global Follicle Stimulating Hormone Sales Market Share by Type in 2025
Figure 14. Global Follicle Stimulating Hormone Revenue Market Share by Type (2020-2025)
Figure 15. Follicle Stimulating Hormone Consumed in Infertility Treatment
Figure 16. Global Follicle Stimulating Hormone Market: Infertility Treatment (2020-2025) & (K Doses)
Figure 17. Follicle Stimulating Hormone Consumed in Assisted Reproductive Technology
Figure 18. Global Follicle Stimulating Hormone Market: Assisted Reproductive Technology (2020-2025) & (K Doses)
Figure 19. Global Follicle Stimulating Hormone Sale Market Share by Application (2024)
Figure 20. Global Follicle Stimulating Hormone Revenue Market Share by Application in 2025
Figure 21. Follicle Stimulating Hormone Sales by Company in 2025 (K Doses)
Figure 22. Global Follicle Stimulating Hormone Sales Market Share by Company in 2025
Figure 23. Follicle Stimulating Hormone Revenue by Company in 2025 ($ millions)
Figure 24. Global Follicle Stimulating Hormone Revenue Market Share by Company in 2025
Figure 25. Global Follicle Stimulating Hormone Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Follicle Stimulating Hormone Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Follicle Stimulating Hormone Sales 2020-2025 (K Doses)
Figure 28. Americas Follicle Stimulating Hormone Revenue 2020-2025 ($ millions)
Figure 29. APAC Follicle Stimulating Hormone Sales 2020-2025 (K Doses)
Figure 30. APAC Follicle Stimulating Hormone Revenue 2020-2025 ($ millions)
Figure 31. Europe Follicle Stimulating Hormone Sales 2020-2025 (K Doses)
Figure 32. Europe Follicle Stimulating Hormone Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Follicle Stimulating Hormone Sales 2020-2025 (K Doses)
Figure 34. Middle East & Africa Follicle Stimulating Hormone Revenue 2020-2025 ($ millions)
Figure 35. Americas Follicle Stimulating Hormone Sales Market Share by Country in 2025
Figure 36. Americas Follicle Stimulating Hormone Revenue Market Share by Country (2020-2025)
Figure 37. Americas Follicle Stimulating Hormone Sales Market Share by Type (2020-2025)
Figure 38. Americas Follicle Stimulating Hormone Sales Market Share by Application (2020-2025)
Figure 39. United States Follicle Stimulating Hormone Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Follicle Stimulating Hormone Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Follicle Stimulating Hormone Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Follicle Stimulating Hormone Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Follicle Stimulating Hormone Sales Market Share by Region in 2025
Figure 44. APAC Follicle Stimulating Hormone Revenue Market Share by Region (2020-2025)
Figure 45. APAC Follicle Stimulating Hormone Sales Market Share by Type (2020-2025)
Figure 46. APAC Follicle Stimulating Hormone Sales Market Share by Application (2020-2025)
Figure 47. China Follicle Stimulating Hormone Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Follicle Stimulating Hormone Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Follicle Stimulating Hormone Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Follicle Stimulating Hormone Revenue Growth 2020-2025 ($ millions)
Figure 51. India Follicle Stimulating Hormone Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Follicle Stimulating Hormone Revenue Growth 2020-2025 ($ millions)
Figure 53. China Taiwan Follicle Stimulating Hormone Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Follicle Stimulating Hormone Sales Market Share by Country in 2025
Figure 55. Europe Follicle Stimulating Hormone Revenue Market Share by Country (2020-2025)
Figure 56. Europe Follicle Stimulating Hormone Sales Market Share by Type (2020-2025)
Figure 57. Europe Follicle Stimulating Hormone Sales Market Share by Application (2020-2025)
Figure 58. Germany Follicle Stimulating Hormone Revenue Growth 2020-2025 ($ millions)
Figure 59. France Follicle Stimulating Hormone Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Follicle Stimulating Hormone Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Follicle Stimulating Hormone Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Follicle Stimulating Hormone Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Follicle Stimulating Hormone Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Follicle Stimulating Hormone Sales Market Share by Type (2020-2025)
Figure 65. Middle East & Africa Follicle Stimulating Hormone Sales Market Share by Application (2020-2025)
Figure 66. Egypt Follicle Stimulating Hormone Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Follicle Stimulating Hormone Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Follicle Stimulating Hormone Revenue Growth 2020-2025 ($ millions)
Figure 69. Turkey Follicle Stimulating Hormone Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Follicle Stimulating Hormone Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Follicle Stimulating Hormone in 2025
Figure 72. Manufacturing Process Analysis of Follicle Stimulating Hormone
Figure 73. Industry Chain Structure of Follicle Stimulating Hormone
Figure 74. Channels of Distribution
Figure 75. Global Follicle Stimulating Hormone Sales Market Forecast by Region (2026-2031)
Figure 76. Global Follicle Stimulating Hormone Revenue Market Share Forecast by Region (2026-2031)
Figure 77. Global Follicle Stimulating Hormone Sales Market Share Forecast by Type (2026-2031)
Figure 78. Global Follicle Stimulating Hormone Revenue Market Share Forecast by Type (2026-2031)
Figure 79. Global Follicle Stimulating Hormone Sales Market Share Forecast by Application (2026-2031)
Figure 80. Global Follicle Stimulating Hormone Revenue Market Share Forecast by Application (2026-2031)